These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 8566121

  • 1. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
    Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A.
    Eur J Pharmacol; 1995 Jul 25; 281(1):81-8. PubMed ID: 8566121
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT.
    Behav Brain Res; 1996 Jul 25; 73(1-2):337-53. PubMed ID: 8788530
    [Abstract] [Full Text] [Related]

  • 3. WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors.
    Fletcher A, Bill DJ, Bill SJ, Cliffe IA, Dover GM, Forster EA, Haskins JT, Jones D, Mansell HL, Reilly Y.
    Eur J Pharmacol; 1993 Jun 24; 237(2-3):283-91. PubMed ID: 8365456
    [Abstract] [Full Text] [Related]

  • 4. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 5. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
    Jackson DM, Wallsten CE, Jerning E, Hu PS, Deveney AM.
    Psychopharmacology (Berl); 1998 Oct 16; 139(4):300-10. PubMed ID: 9809851
    [Abstract] [Full Text] [Related]

  • 6. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist.
    Defraiteur C, Plenevaux A, Scuvée-Moreau J, Rouchet N, Goblet D, Luxen A, Seutin V.
    Br J Pharmacol; 2007 Nov 16; 152(6):952-8. PubMed ID: 17704821
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar 16; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 8. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG, Beneytez ME, Delgado M, Manzanares J, López-Rodríguez ML, Benhamu B, Morcillo MJ, Pozo MA, Rubia FJ, Fuentes JA.
    Pharmacology; 2001 May 16; 62(4):234-42. PubMed ID: 11360001
    [Abstract] [Full Text] [Related]

  • 9. WAY-100635 and GR127935: effects on 5-hydroxytryptamine-containing neurones.
    Craven R, Grahame-Smith D, Newberry N.
    Eur J Pharmacol; 1994 Dec 12; 271(1):R1-3. PubMed ID: 7698189
    [Abstract] [Full Text] [Related]

  • 10. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing.
    Mundey MK, Fletcher A, Marsden CA.
    Br J Pharmacol; 1996 Feb 12; 117(4):750-6. PubMed ID: 8646424
    [Abstract] [Full Text] [Related]

  • 11. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
    Zuideveld KP, Treijtel N, Maas HJ, Gubbens-Stibbe JM, Peletier LA, van Der Graaf PH, Danhof M.
    J Pharmacol Exp Ther; 2002 Jan 12; 300(1):330-8. PubMed ID: 11752133
    [Abstract] [Full Text] [Related]

  • 12. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB, Koek W.
    Eur J Pharmacol; 2000 Dec 08; 409(2):173-7. PubMed ID: 11104831
    [Abstract] [Full Text] [Related]

  • 13. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF, Lesourd M, Mocaer E, Koolhaas JM.
    J Pharmacol Exp Ther; 1999 Mar 08; 288(3):1125-33. PubMed ID: 10027850
    [Abstract] [Full Text] [Related]

  • 14. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC, Malagié I, Mathé-Allainmat M, Anmela MC, Jacquot C, Langlois M, Gardier AM.
    Eur J Pharmacol; 1998 Apr 17; 347(1):41-9. PubMed ID: 9650846
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635.
    Critchley DJ, Childs KJ, Middlefell VC, Dourish CT.
    Eur J Pharmacol; 1994 Oct 13; 264(1):95-7. PubMed ID: 7828650
    [Abstract] [Full Text] [Related]

  • 16. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP, Jackson DM, Wallsten C, Waszczak BL.
    J Pharmacol Exp Ther; 1999 Feb 13; 288(2):820-6. PubMed ID: 9918594
    [Abstract] [Full Text] [Related]

  • 17. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, Verriele L.
    J Pharmacol Exp Ther; 1992 Aug 13; 262(2):451-63. PubMed ID: 1323650
    [Abstract] [Full Text] [Related]

  • 18. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
    Vicentic A, Li Q, Battaglia G, Van de Kar LD.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):261-6. PubMed ID: 9652368
    [Abstract] [Full Text] [Related]

  • 19. Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits.
    Ootsuka Y, Blessing WW.
    Brain Res; 2006 Feb 16; 1073-1074():252-61. PubMed ID: 16455061
    [Abstract] [Full Text] [Related]

  • 20. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
    Hajós M, Hajós-Korcsok E, Sharp T.
    Br J Pharmacol; 1999 Apr 16; 126(8):1741-50. PubMed ID: 10372816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.